Skip to main content
Equibles

Perrin Wilson

Climb Bio, Inc. (CLYM)

Equibles does not estimate personal net worth.

Get an email with a short summary when Climb Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get CLYM alerts

About Perrin Wilson

The proxy statement of Climb Bio, Inc. reports total compensation of $1,537,367 for Perrin Wilson in fiscal 2025, including a base salary of $406,875. Perrin Wilson has spoken on 2 investor events across 1 company, most recently for Climb Bio, Inc. on September 16, 2026. Climb Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Climb Bio, Inc. includes Aoife Brennan (CEO, CFO and Board Member), Aoife Brennan, M.B., Ch.B. (CEO and Board Member), Dr. Stephen Thomas (CEO) and 7 others.

Perrin Wilson on recent calls

“Yeah, I think, you know, what Aoife touched on are two elements of the IGAM market that are important.”
Other, Morgan Stanley 24th Annual Global Healthcare Conference ·
“Yeah sure so we think you know CD19 is a really emerging as you know a really validated target with a Blinza sharing they're leaning into their experience and in neuro diseases in the INI space and you If you look at the expression of CD19 relative to CD20, CD19 is really expressed more broadly across the B-cell…”
Other, H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Click here for webcast ·

Affiliation history

Company network

Leadership on record at Climb Bio, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Climb Bio, Inc. (CLYM) $406,875 $1,537,367

Recent activity